In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.

Key opinion leaders discuss the single FDA-approved option for primary progressive multiple sclerosis and emerging therapies under investigation for this MS subtype, examine the PERSEUS trial, and ...

Add Yahoo as a preferred source to see more of our stories on Google. While 2.3 million people worldwide have multiple sclerosis, there’s a lot most people don’t understand about the disease. Multiple ...

Ludwig Kappos, MD, a neurologist in Switzerland, wins the 2026 Dystel Prize for his work advancing understanding of MS.

Dr Sunandana Chandra highlights her personal experience in prescribing tebentafusp and other therapies for mUM, and discusses the educational resources and advocacy organizations that she encourages ...

An overview of the FIDELITY analysis, which pooled data from the FIGARO-DKD and FIDELIO-DKD trials in patients with type 2 diabetes and CKD. Rajiv Agarwal, MD, MS, shares expert insight on the results ...

Maryland first lady Dawn Moore recently revealed something very personal to the world. For more than 20 years, she has lived with multiple sclerosis or MS. Her announcement comes during Multiple ...